Signal active
Bio
Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST) program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.
As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.
Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.
Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU. He's married to Katie Rae, another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.
Location
Cambridge, Massachusetts, United States, North America
Social
Primary Organization
1861
25
9
5
10001+
Education, Higher Education, Universities
Jobs history
4
Apex Neuro
Founder
2016 - Current
Abridge
Board Director
2019 - Current
Apex Neuro
Chairman of the Board
2016 - Current
Feelmore Labs
Co-Founder
2016 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Zen Chu is the Founder Senior Lecturer, Faculty Director for MIT HST.978 Healthcare Ventures + MIT Hacking Medicine at Massachusetts Institute of Technology, based in United States, North America. With a background in Education, Zen Chu has a rich history of leadership and innovation. Zen Chu studied Master's Public & Private Management @ Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
4
2
Personal investment
4
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jul 01, 2013 | PillPack | Series A - PillPack | 3.5M |
Dec 09, 2013 | Figure 1 | Seed Round - Figure 1 | 2.0M |
Oct 06, 2020 | Abridge | Series A - Abridge | 10.0M |
Jun 01, 2022 | MycoMedica Life Sciences, PBC | Series A - MycoMedica Life Sciences, PBC | 60.0M |
Partner investment
2
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Oct 29, 2018 | - | Seed Round - Filtricine | Zen Chu | 5.0M |
Jun 01, 2022 | MycoMedica Life Sciences, PBC | Series A - MycoMedica Life Sciences, PBC | Zen Chu | 60.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.